Suppressive effect of 1α,25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: Impairment of functional activities and chemotaxis

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 270-276

  Gauzzi, Maria Cristina ^a   Purificato, Cristina ^a   Donato, Karim ^a   Jin, Yixin ^b   Wang, Ling ^c   Daniel, Kenn C ^b   Maghazachi, Azzam A ^c   Belardelli, Filippo ^a   Adorini, Luciano ^b   Gessani, Sandra ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BioXell SpA   (Italy)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; BETA CHEMOKINE CCL19; BETA CHEMOKINE CCL4; CALCITRIOL; CALCIUM ION; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; INTERFERON; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CHEMOKINE; VITAMIN D;

ARTICLE; CALCIUM TRANSPORT; CELL DEATH; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELLULAR IMMUNITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE; NEUTROPHIL CHEMOTAXIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIFFERENTIATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE I; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITAMIN D;

EID: 19944389229     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.270     Document Type: Article

References (50)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.-J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
2. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685.
3. Moser, M. 2003. Dendritic cells in immunity and tolerance: do they display opposite functions? Immunity 19:5.
4. McColl, S. R. 2002. Chemokines and dendritic cells: a crucial alliance. Immunol. Cell Biol. 80:489.
5. Belardelli, F., and I. Gresser. 1996. The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol. Today 17:369.
6. Le Bon, A., and D. F. Tough. 2002. Links between innate and adaptive immunity via type 1 interferon. Curr. Opin. Immunol. 14:432.
7. Santini, S. M., T. Di Pucchio, C. Lapenta, S. Parlato, M. A. Logozzi, and F. Belardelli. 2002. The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J. Interferon Cytokine Res. 22:1071.
8. Paquette, R. L., N. C. Hsu, S. M. Kiertscher, A. N. Park, L. Tran, M. D. Roth, and J. A. Glaspy. 1998. Interferon-α and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J. Leukocyte Biol. 64:358.
9. Luft, T., K. C. Pang, E. Thomas, P. Hertzog, D. N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947.
10. Bartholome, E. J., F. Willems, A. Crusiaux, K. Thielemans, L. Schandene, and M. Goldman. 1999. IFN-β interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: selective inhibition of CD40-dependent interleukin-12 secretion. J. Interferon Cytokine Res. 19:471.
11. + precursors. Blood 96:210.
12. Dauer, M., K. Pohl, B. Obermaier, T. Meskendahl, J. Robe, M. Schnurr, S. Endres, and A. Eigler. 2003. Interferon-α disables dendritic cell precursors: dendritic cells derived from interferon-α-treated monocytes are defective in maturation and T-cell stimulation. Immunology 110:38.
13. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 191:1777.
14. Lapenta, C., S. M. Santini, M. Logozzi, M. Spada, M. Andreotti, T. Di Pucchio, S. Parlato, and F. Belardelli. 2003. Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-α. J. Exp. Med. 198:361.
15. Parlato, S., S. M. Santini, C. Lapenta, T. Di Pucchio, M. Logozzi, M. Spada, A. M. Giammarioli, W. Malorni, S. Fais, and F. Belardelli. 2001. Expression of CCR-7, MIP-3β, and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities. Blood 98:3022.
16. 3 analogs as immunomodulatory agents. Trends Mol. Med. 8:174.
17. Christakos, S., P. Dhawan, Y. Liu, X. Peng, and A. Porta. 2003. New insights into the mechanisms of vitamin D action. J. Cell. Biochem. 88:695.
18. 3. Curr. Opin. Nephrol. Hyperten. 4:313.
19. Adorini, L. 2002. Immunomodulatory effect of vitamin D receptor ligands in autoimmune disease. Int. Immunopharmacol. 2:1017.
20. 3 analogs as potential therapies in transplantation. Curr. Opin. Investing. Drugs 3:1458.
21. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2405.
22. 3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 164:4443.
23. Griffin, M. D., W. H. Lutz, V. A. Phan, L. A. Bachaman, D. J. McKean, and R. Kumar. 2000. Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 270:701.
24. 3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98:6800.
25. 3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167:1945.
26. 3 analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367.
27. Maghazachi, A. A., B. S. Skalhegg, B. Rolstad, and A. Al-Aoukaty. 1997. Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 10:765.
28. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821.
29. Gauzzi, M. C., I. Canini, P. Eid, F. Belardelli, and S. Gessani. 2002. Loss of type I IFN receptors and impaired IFN responsiveness during terminal maturation of monocyte-derived human dendritic cells. J. Immunol. 169:3038.
30. Remoli, M. E., E. Giacomini, G. Luftalla, E. Dondi, G. Orefici, A. Battistini, G. Uze, S. Pellegrini, and E. M. Coccia. 2002. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J. Immunol. 169:366.
31. 3. Crit. Rev. Eukaryotic Gene Expression 8:19.
32. Blanco, P., A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294:1540.
33. Griffin, M. D., N. Xing, and R. Kumar. 2003. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu. Rev. Nutr. 23:117.
34. Hewison, M., L. Freeman, S. V. Hughes, K. N. Evans, R. Bland, A. G. Eliopoulos, M. D. Kilby, P. A. Moss, and R. Chakraverty. 2003. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 170:5382.
35. 3 by human dendritic cells. Blood 102:3314.
36. 3) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 145:351.
37. 3. Diabetes 51:2119.
38. 3 on inflammatory responses in psoriasis. Eur. J. Dermatol. 8:16.
39. Shortman, K., and Y.-J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151.
40. Diebold, S. S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L. E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324.
41. Cella, M., F. Facchetti, A. Lanzavecchia, and M. Colonna. 2002. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent Th1 polarization. Nat. Immunol. 1:305.
42. Patterson, S. 2000. Flexibility and cooperation among dendritic cells. Nat. Immunol. 1:273.
43. D'Amico, G., G. Frascaroli, G. Bianchi, P. Transidico, A. Doni, A. Vecchi, S. Sozzani, P. Allavena, and A. Mantovani. 2000. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat. Immunol. 1:387.
44. Penna, G., S. Sozzani, and L. Adorini. 2001. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 167:1862.
45. Maghazachi, A. A. 2000. Intracellular signaling events at the leading edge of migrating cells. Int. J. Biochem. Cell Biol. 32:931.
46. Ward, S. G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9:1.
47. Saw, K., H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto, K. Tadokoro, T. Juji, and T. A. Takahashi. 2001. Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages. Int. Immunol. 13:167.
48. Ravid, A., E. Rubinstein, A. Gamady, C. Rotem, U. A. Liberman, and R. Koren. 2002. Vitamin D inhibits the activation of stress-activated protein kinases by physiological and environmental stresses in keratinocytes. J. Endocrinol. 173:525.
49. 3: activation of muscle cell PLCγ through the tyrosine kinase c-Src and PtdIns 3-kinase. Eur. J. Biochem. 269:2506.
50. 3 alters Syk activation through Fcγ RII in monocytic THP-1 cells. J. Cell. Biochem. 89:1056.